DCIS in America: diagnosis, terminology and care

The wording can sound alarming, but DCIS is non-invasive: the abnormal cells have not broken through the duct wall into surrounding breast tissue. Its location, extent and pathology features help the care team discuss management.

DCIS is commonly detected as calcifications on a mammogram rather than through a change someone can feel. A breast biopsy provides tissue for a pathologist to confirm that the abnormal cells remain inside the ducts. The report may describe grade, size or extent, margins after surgery, and hormone-receptor findings. These details are more useful for planning than the label alone.

Arrange a visit with a breast surgeon to review the mammogram, biopsy site and pathology together. Treatment can involve lumpectomy, sometimes followed by radiotherapy, or mastectomy when the area is extensive or breast-conserving surgery is not suitable. Hormone therapy may be discussed for hormone-receptor-positive DCIS. The appropriate combination depends on the tissue findings, breast anatomy, other health conditions and your preferences.

Keep copies of imaging and pathology reports, note whether the diagnosis was found in one area or several, and ask whether another pathology review would change the plan.

Contact the treating team promptly for increasing redness, warmth, swelling, drainage, fever or worsening pain after a biopsy or operation. Before treatment, arrange assessment for a new breast lump, bloody nipple discharge, nipple inversion, skin dimpling or a persistent change near the biopsy area. These changes need examination; they do not by themselves establish invasive cancer.

Ask: Is the diagnosis entirely DCIS? What do the grade and imaging extent show? Can surgery conserve the breast, and how will margins be checked? Would radiotherapy or hormone therapy add a meaningful benefit in my situation? What follow-up imaging will I need, and which new breast changes should prompt an earlier visit?